At what stages of the drug development lifecycle do I need legal counsel?

You effectively need legal guidance at every single step of the five-stage process, starting from the initial Discovery phase where intellectual property must be secured. The need for counsel intensifies during Pre-clinical and Clinical trials to manage patient safety contracts, peaks during the Regulatory Review phase to handle government queries, and continues through Post-Market monitoring to defend against safety lawsuits.

How can a lawyer help with FDA (or EMA) regulatory approval?

A lawyer acts as your strategic interpreter during the approval process, helping you choose the correct pathway—such as the 505(b)(2) route in the US—to avoid unnecessary clinical trials. They review your application to ensure your data presentation meets the strict statutory standards of safety and efficacy, which is critical given that the US FDA approved only 50 new drugs in 2024. If the agency issues a Complete Response Letter (a rejection), a lawyer helps you draft the legal arguments to appeal the decision or restructure your resubmission to fix the identified deficiencies.

What are the unique challenges of patenting biotechnology or genes?

The biggest hurdle in biotech is the "subject matter eligibility" rule, which essentially states you cannot patent a product of nature. Since the US Supreme Court's 2013 Myriad Genetics ruling , you cannot patent a naturally occurring human gene even if you isolate it, meaning lawyers must draft claims that focus on the non-natural methods of using or modifying the gene (like cDNA) rather than the gene itself. This creates a complex legal minefield where a single poorly written sentence can render a billion-dollar invention unpatentable because it sounds too much like a natural discovery.

Do I need a lawyer to draft a Clinical Trial Agreement (CTA)?

Yes, because the CTA dictates who is financially responsible if a volunteer gets hurt during your study. A lawyer negotiates the "Subject Injury" and "Indemnification" clauses to ensure that your company is not liable for medical costs resulting from the trial site's negligence rather than your drug. Furthermore, they protect your ownership of the data generated during the trial, preventing the hospital or university running the study from publishing your trade secrets before you have a chance to file for patent protection.

How do lawyers handle liability issues for medical devices?

Lawyers defend device manufacturers primarily against "strict liability" claims, where a plaintiff does not need to prove you were negligent, only that the product was defective and caused harm. They often use the "preemption" defense for Class III devices (the highest risk category), arguing that because the FDA rigorously approved the device's specific design and warnings, state laws cannot impose additional liability requirements. This defense is vital in an industry where large-scale product liability settlements can reach billions of dollars.

What are the legal rules regarding pharmaceutical marketing and advertising?

The rules depend entirely on where your audience is located due to a massive regulatory divide. In the United States, lawyers ensure your ads meet the "fair balance" standard, meaning the presentation of risks must be as prominent as the benefits; however, in the United Kingdom, direct-to-consumer advertising for prescription medicine is strictly banned to protect public health. A lawyer reviews every piece of marketing material to ensure you don't accidentally trigger a federal investigation for "off-label promotion," which occurs if you market a drug for a use the government hasn't explicitly approved.

How does a lawyer structure an R&D collaboration between a university and a pharma company?

These deals are structured around the Bayh-Dole Act , a US law that allows universities to own the patents for inventions created with federal funding. A lawyer negotiates a "license agreement" where the university keeps the patent title but grants the pharma company the exclusive commercial rights to develop and sell the final product. The contract must carefully define "Milestone Payments" and "Royalties" to ensure the university gets paid fairly if the drug succeeds without crippling the company’s profit margins.

527 lawyers active worldwide

Life Sciences Lawyers Worldwide.

0+ Countries

Gold Standard

Articles

Stay Informed

Life Sciences News

Practice Area

Patent vs Trade Secret in Germany: Which IP Protection Should Life‑sciences Companies Choose?

Dr. Christian Rybak2mo ago

Practice Area

What Is the NUB Process in Germany (2026): Who Can Apply, Inek Deadlines, Status 1 and G‑BA Interactions

Dr. Christian Rybak2mo ago

Practice Area

What Is the NUB Process in Germany (2026): Who Can Apply, Inek Deadlines, Status 1 & G‑BA Steps

Dr. Christian Rybak2mo ago

Practice Area

Germany Life Sciences Regulation in 2025: Navigating the EU Pharma Package, IVDR Compliance and Clinical Trial Reforms

Dr. Christian Rybak3mo ago

Practice Area

Distributor vs Commercial Agent vs Subsidiary in Germany (2026): Which Market‑entry Model Is Best for Pharma, Medtech & Digital‑health?

Dr. Christian Rybak3mo ago

Practice Area

Step‑by‑step Clinical Trial Authorisation Process in Germany (CTIS, Ethics & National Rules)

Dr. Christian Rybak3mo ago

Common Questions

Life Sciences FAQ

A Life Sciences lawyer supports a wide range of companies that research, develop, or manufacture health products. This primarily includes the "Big Three" sectors of pharmaceuticals, biotechnology, and medical devices, but the field has rapidly expanded to include digital health, genomics, and agricultural tech (AgTech). Since the global life sciences legal market is largely driven by innovation, lawyers in this space also represent university research labs and venture capital funds.

Need a Life Sciences lawyer?

Tell us what you need and we'll connect you with a vetted expert in the right jurisdiction — usually within hours.

Get Matched Now